Source: Jepsen , D B , Ryg , J , Hansen , S , Jørgensen , N R , Gram , J & Masud , T 2019 , ' The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia:A 6-Year Prospective Cohort Study

Authors : Shanbhogue, Vikram Vinod; Hansen, Stinus; Jørgensen, Niklas Rye

Subjects: Adolescent; Adult; Aged

Source: Shanbhogue , V V , Hansen , S , Jørgensen , N R & Beck-Nielsen , S S 2018 , ' Impact of Conventional Medical Therapy on Bone Mineral

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy

Authors : Peters, Geeske; Tett, Susan; Duncan, Emma

Subjects: 21st Century; Aged; Australia

Source: Pharmacoepidemiology and Drug Safety

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Authors : Hadji, Peyman; Gnant, Michael; Body, Jean-Jacques

Subjects: Sciences bio-médicales et agricoles; Amenorrhea -- chemically induced -- epidemiology; Antineoplastic Agents -- adverse effects -- therapeutic use

Source: Cancer treatment reviews, 38 (6

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

Recommendations on the management of fragility fracture risk in women younger than 70 years.

Authors : Palacios, Santiago; Christiansen, Claus; Sánchez Borrego, Rafael

Subjects: Sciences bio-médicales et agricoles; Aged; Antineoplastic Agents -- adverse effects -- therapeutic use

Source: Gynecological endocrinology, 28 (10

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

Authors : Palacios, Santiago; Brincat, Mark; Erel, C Tamer

Subjects: Sciences bio-médicales et agricoles; Antibodies, Monoclonal -- therapeutic use; Antibodies, Monoclonal, Humanized

Source: Maturitas, 71 (2

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Authors : Hadji, Peyman; Gnant, Michael; Body, Jean-Jacques

Subjects: Sciences bio-médicales et agricoles; Amenorrhea -- chemically induced -- epidemiology; Antineoplastic Agents -- adverse effects -- therapeutic use

Source: Cancer treatment reviews, 38 (6

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Electronic Resource

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

Authors : Palacios, Santiago; Brincat, Mark; Erel, C Tamer

Subjects: Sciences bio-médicales et agricoles; Antibodies, Monoclonal -- therapeutic use; Antibodies, Monoclonal, Humanized

Source: Maturitas, 71 (2

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

A model-based cost-effectiveness analysis of fracture liaison services in China

Osteoporose en verhoogd fractuurrisico

The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study):a randomized controlled trial

Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia:A 6-Year Prospective Cohort Study

Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Recommendations on the management of fragility fracture risk in women younger than 70 years.

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

اتصل بنا

اتبع